Alipogene tiparvovec (Glybera) is a drug synthesized to counter Lipoprotein lipase deficiency (LPLD), a genetic disorder that is known to cause pancreatitis. It was meant to be a means of gene therapy for individuals with LPLD. This drug was approved…   Read more»